Wolverine Trading
NTLA icon

Wolverine Trading’s Intellia Therapeutics NTLA Stock Holding History

Wolverine Trading’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$363K Buy
+21,438
New +$264K ﹤0.01% 4105
2025
Q1 		– Sell
-31,015
Closed -$313K – 5487
2024
Q4 		$354K Buy
31,015
+20,314
+190% +$317K ﹤0.01% 3831
2024
Q3 		$225K Sell
10,701
-768
-7% -$17.7K ﹤0.01% 3958
2024
Q2 		$257K Buy
11,469
+571
+5% +$13.6K ﹤0.01% 3560
2024
Q1 		$300K Sell
10,898
-913
-8% -$25.4K ﹤0.01% 3356
2023
Q4 		$360K Buy
11,811
+1,028
+10% +$29.5K ﹤0.01% 3289
2023
Q3 		$341K Buy
10,783
+4,315
+67% +$167K ﹤0.01% 3167
2023
Q2 		$265K Buy
+6,468
New +$262K ﹤0.01% 3232
2023
Q1 		– Sell
-7,964
Closed -$312K – 4720
2022
Q4 		$278K Buy
7,964
+3,719
+88% +$177K ﹤0.01% 2826
2022
Q3 		$235K Sell
4,245
-231
-5% -$14.3K ﹤0.01% 3411
2022
Q2 		$235K Sell
4,476
-719
-14% -$36.5K ﹤0.01% 3365
2022
Q1 		$375K Sell
5,195
-362
-7% -$30.7K ﹤0.01% 3619
2021
Q4 		$674K Sell
5,557
-992
-15% -$124K ﹤0.01% 3080
2021
Q3 		$901K Buy
6,549
+4,277
+188% +$648K ﹤0.01% 3119
2021
Q2 		$344K Sell
2,272
-6,100
-73% -$475K ﹤0.01% 4226
2021
Q1 		$605K Buy
+8,372
New +$562K ﹤0.01% 3447

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's NTLA Position: Q3 2025 in Review

Wolverine Trading opened a new position in Intellia Therapeutics (NTLA) in Q3 2025: 21,438 shares worth $363K. The stake represents ﹤0.01% of the portfolio and ranks #4105 among its holdings. This is a return to the name: Wolverine Trading previously reported a position in NTLA as recently as Q4 2024.

Wolverine Trading first reported a position in NTLA in Q1 2021 and has held it in 16 quarters since. The position peaked at $901K in Q3 2021. 282 funds tracked by Wall St. Rank hold NTLA as of Q3 2025.

  • Wolverine Trading held 21,438 shares of Intellia Therapeutics worth $363K as of Q3 2025.
  • Intellia Therapeutics was a new Wolverine Trading position in Q3 2025.
  • Intellia Therapeutics made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #4105 holding.
  • Wolverine Trading first reported a position in Intellia Therapeutics in Q1 2021 and has held it in 16 quarters since.
  • Wolverine Trading's Intellia Therapeutics position peaked at $901K in Q3 2021.
  • 282 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.